Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort

Rasmus Sørrig1,2, Tobias W Klausen3, Morten Salomo1

  • 1Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

Abstract

Insights

Infections are a major risk in Multiple Myeloma (MM). This study identified tumor burden and kidney issues as key risk factors for early pneumonia and sepsis in MM patients.

Area of Science:

  • Hematology
  • Oncology
  • Infectious Diseases

Background:

  • Infections represent a significant threat, causing early mortality in Multiple Myeloma (MM) patients.
  • Limited research exists on identifying specific risk factors for infections in this vulnerable population.

Purpose of the Study:

  • To investigate and analyze the risk factors associated with infections in a population-based cohort of Multiple Myeloma patients.
  • To identify predictors of early-phase infections, specifically pneumonia and sepsis, in newly diagnosed MM patients.

Main Methods:

  • Utilized Danish national registries from 2005 to 2013.
  • Analyzed ICD-10 codes for infections within the first six months post-diagnosis in 2557 Multiple Myeloma patients.

Main Results:

  • Pneumonia and sepsis accounted for 46% of all infections.
  • Risk factors for pneumonia included male gender, advanced ISS stages (II/III), and elevated LDH.
  • Risk factors for sepsis included high bone marrow plasma cell percentage, advanced ISS stages (II/III), and elevated creatinine.
  • Neither immunoparesis nor comorbidity emerged as significant risk factors.

Conclusions:

  • Tumor burden (indicated by ISS stage and plasma cell percentage) and renal impairment are significant risk factors for developing pneumonia and sepsis in the early stages of Multiple Myeloma.
  • These findings highlight the importance of monitoring these factors for proactive infection management in MM patients.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
240
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.1K